135 related articles for article (PubMed ID: 34080979)
1. A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients.
Arne V; Canan G; Marjan G
Eur J Dermatol; 2021 Jun; 31(3):364-371. PubMed ID: 34080979
[TBL] [Abstract][Full Text] [Related]
2. Melanoma in a cohort of organ transplant recipients: Experience from a dedicated transplant dermatology clinic in Victoria, Australia.
Maor D; Vajdic CM; Cumming S; Fahey V; Bala HR; Snaidr V; Brennand S; Goh MSY; Chong AH
J Am Acad Dermatol; 2020 Sep; 83(3):773-779. PubMed ID: 31706934
[TBL] [Abstract][Full Text] [Related]
3. [Melanoma in organ transplant patients].
Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
[TBL] [Abstract][Full Text] [Related]
4. Melanoma Risk and Survival among Organ Transplant Recipients.
Robbins HA; Clarke CA; Arron ST; Tatalovich Z; Kahn AR; Hernandez BY; Paddock L; Yanik EL; Lynch CF; Kasiske BL; Snyder J; Engels EA
J Invest Dermatol; 2015 Nov; 135(11):2657-2665. PubMed ID: 26270022
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality.
Krynitz B; Rozell BL; Lyth J; Smedby KE; Lindelöf B
J Am Acad Dermatol; 2015 Jul; 73(1):106-113.e2. PubMed ID: 25929720
[TBL] [Abstract][Full Text] [Related]
6. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.
Bangash HK; Colegio OR
Curr Treat Options Oncol; 2012 Sep; 13(3):354-76. PubMed ID: 22592596
[TBL] [Abstract][Full Text] [Related]
7. Melanoma Incidence and Lethality Is Increased Following Solid Organ Transplantation.
Whiteman DC; Olsen CM
J Invest Dermatol; 2015 Nov; 135(11):2560-2562. PubMed ID: 26548485
[TBL] [Abstract][Full Text] [Related]
8. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
[TBL] [Abstract][Full Text] [Related]
9. Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study.
Fattouh K; Ducroux E; Decullier E; Kanitakis J; Morelon E; Boissonnat P; Sebbag L; Jullien D; Euvrard S
Transpl Int; 2017 Nov; 30(11):1172-1180. PubMed ID: 28700114
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous melanoma in solid organ transplant patients.
Russo I; Piaserico S; Belloni-Fortina A; Alaibac M
G Ital Dermatol Venereol; 2014 Aug; 149(4):389-94. PubMed ID: 25068225
[TBL] [Abstract][Full Text] [Related]
11. Melanomas in renal transplant recipients.
Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
[TBL] [Abstract][Full Text] [Related]
12. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.
Morton DL; Davtyan DG; Wanek LA; Foshag LJ; Cochran AJ
Cancer; 1993 Jun; 71(11):3737-43. PubMed ID: 8490924
[TBL] [Abstract][Full Text] [Related]
14. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
15. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
16. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
Kovach BT; Sams HH; Stasko T
Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
[TBL] [Abstract][Full Text] [Related]
17. Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: a cohort study.
Oh CC; Hofbauer GFL; Serra AL; Harwood CA; Mitchell L; Proby CM; Olasz EB; Mosel DD; Piaserico S; Fortina AB; Geusau A; Jahn-Bassler K; Gerritsen MJP; Seçkin D; Güleç AT; Cetkovská P; Ricar J; Imko-Walczuk B; Dębska-Ślizień A; Bouwes Bavinck JN
Br J Dermatol; 2017 May; 176(5):1179-1186. PubMed ID: 28012178
[TBL] [Abstract][Full Text] [Related]
18. Deep cutaneous fungal infections in solid-organ transplant recipients.
Galezowski A; Delyon J; Le Cleach L; Guégan S; Ducroux E; Alanio A; Lastennet D; Moguelet P; Dadban A; Leccia MT; Le Pelletier F; Francès C; Lebbé C; Barete S;
J Am Acad Dermatol; 2020 Aug; 83(2):455-462. PubMed ID: 31931081
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.
Williams K; Mansh M; Chin-Hong P; Singer J; Arron ST
Clin Infect Dis; 2014 Apr; 58(7):997-1002. PubMed ID: 24363331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
